Jeffrey Gudin's Net Worth

$0

Estimate Recalculated Jul 15, 2024 05:43PM EST

Who is Jeffrey Gudin?

Jeffrey Gudin does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Virpax Pharmaceuticals, Inc..

SEC CIK

Jeffrey Gudin's CIK is 0001818449

Past Insider Trading and Trends

2022 was Jeffrey Gudin's most active year for acquiring shares with 2 total transactions. Jeffrey Gudin's most active month to acquire stocks was the month of December. 2022 saw Jeffrey Gudin paying a total of $0.00 for 160,676 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Virpax Pharmaceuticals, Inc. (VRPX) Snapshot price: $0.3697

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 25
Form 4/A
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Apr 7
Form 3
—
0
—
—
0
No matching records found